Integer Holdings (ITGR) Net Income towards Common Stockholders Growth (1y) (2011 - 2025)
Integer Holdings (ITGR) Net Income towards Common Stockholders Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 121.14% |
| 10 | Integer Holdings | 3.40 Bn | 3.40 Bn | 109.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2025 | 73.49% |
| Dec 31, 2024 | 40.79% |
| Sep 27, 2024 | 8.07% |
| Jun 28, 2024 | -99.84% |
| Mar 29, 2024 | -100.64% |
| Dec 31, 2023 | -103.98% |
| Sep 29, 2023 | -105.71% |
| Jun 30, 2023 | 15.05% |
| Mar 31, 2023 | 15.43% |
| Dec 31, 2022 | -42.84% |
| Sep 30, 2022 | -27.28% |
| Jul 1, 2022 | -29.21% |
| Apr 1, 2022 | -47.40% |
| Dec 31, 2019 | -100.31% |
| Jun 28, 2019 | 262.49% |
| Mar 29, 2019 | 104.85% |
| Dec 28, 2018 | 883.33% |
| Sep 28, 2018 | 2,731.30% |
| Jun 29, 2018 | 53.81% |
| Mar 30, 2018 | -44.02% |